Debra Sarasohn

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 7 papers. Top paper: “A phase 2 trial of zanidatamab in HER2-overexpressed advanced endometrial carcinoma and carcinosarcoma (ZW25-IST-2)”.

A phase 2 trial of zanidatamab in HER2-overexpressed advanced endometrial carcinoma and carcinosarcoma (ZW25-IST-2)

Gynecologic Oncology(2024)10.1016/j.ygyno.2023.12.028

N/A

0.583DataRank · unranked

12 citations

M. Herman Chui, Qin Zhou, Alexia Iasonos, Debra Sarasohn, Seth M. Cohen +9 more

Waxing and waning pattern of mTOR inhibitor-associated pneumonitis in renal cell carcinoma patients: A retrospective observational study

Clinical Imaging(2020)10.1016/j.clinimag.2020.10.052

N/A

0DataRank · unranked

4 citations

Andrew J. Plodkowski, Jeffrey Girshman, Debra Sarasohn, A. Viteri, Sumar Hayan +2 more

Durvalumab with or without tremelimumab in patients with persistent or recurrent endometrial cancer or endometrial carcinosarcoma: A randomized open-label phase 2 study

Gynecologic Oncology(2022)10.1016/j.ygyno.2022.11.028

N/A

0DataRank · unranked

23 citations

Eric Rios Doria, Jason Konner, Stuart M. Lichtman, Qin Zhou, Alexia Iasonos +18 more

A multimodality triage algorithm to improve cytoreductive outcomes in patients undergoing primary debulking surgery for advanced ovarian cancer: A Memorial Sloan Kettering Cancer Center team ovary initiative

Gynecologic Oncology(2020)10.1016/j.ygyno.2020.05.041

N/A

0DataRank · unranked

34 citations

Olga T. Filippova, Renee A. Cowan, Yulia Lakhman, Debra Sarasohn, Ines Nikolovski +9 more

Tumor lenvatinib addiction and withdrawal rebound response in patients with advanced endometrial cancer

Gynecologic Oncology Reports(2023)10.1016/j.gore.2023.101258

N/A

0DataRank · unranked

3 citations

Debra Sarasohn, Britta Weigelt, Dmitriy Zamarin, Clarissa Lam

A prospective comparison of resectability scores to enhance preoperative decision-making in the primary management of advanced ovarian cancer: a Memorial Sloan Kettering Cancer Center Team Ovary study

International Journal of Gynecological Cancer(2025)10.1016/j.ijgc.2025.102662

N/A

0DataRank · unranked

2 citations

Kimberly Murphy, Kaothar Oladoja, Effi Yeoshoua, Lindsey Finch, Christina Harlev +16 more

Phase I Study of a Multivalent WT1 Peptide Vaccine (Galinpepimut-S) in Combination with Nivolumab in Patients with WT1-Expressing Ovarian Cancer in Second or Third Remission

Cancers(2023)10.3390/cancers15051458

N/A

0DataRank · unranked

20 citations

Sacha Gnjatic, Carol Aghajanian, Jason Konner, Sarah H. Kim, Debra Sarasohn +12 more